NPI: 1457648172 · KEYSER, WV 26726 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/01/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/01/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,274 | $57K |
| 2019 | 6,187 | $162K |
| 2020 | 6,292 | $481K |
| 2021 | 507 | $10K |
| 2022 | 948 | $8K |
| 2023 | 317 | $9K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 5,630 | 507 | $580K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,108 | 552 | $64K |
| A4657 | Syringe, with or without needle, each | 819 | 441 | $35K |
| J1756 | Injection, iron sucrose, 1 mg | 1,512 | 444 | $30K |
| J1270 | Injection, doxercalciferol, 1 mcg | 525 | 49 | $16K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 56 | 39 | $3K |
| 83970 | 85 | 79 | $32.58 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 51 | 50 | $13.71 |
| 83550 | 82 | 77 | $8.67 | |
| 82728 | 66 | 64 | $8.16 | |
| 85041 | 234 | 209 | $6.12 | |
| 85048 | 233 | 208 | $5.06 | |
| 82108 | 14 | 13 | $4.81 | |
| 83540 | 67 | 65 | $4.13 | |
| 82607 | 14 | 12 | $2.22 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 15 | 12 | $2.22 |
| 82746 | 14 | 12 | $2.16 |